Literature DB >> 8789606

Distribution of tripeptidyl-peptidase II in the central nervous system of rat.

B Tomkinson1, F Nyberg.   

Abstract

Tripeptidyl-peptidase II (TPP II) is a high molecular weight serine peptidase which removes tripeptides from a free N-terminus of longer peptides. Since it had previously been demonstrated that the enzyme can inactivate enkephalins and dynorphins in vitro by removing the N-terminal Tyr-Gly-Gly peptide, we wanted to see whether TPP II could be involved in this process also in vivo. Therefore, the localization of TPP II in different cerebral regions of rat was investigated by immunoblot analysis and activity measurements. It could be shown that TPP II is relatively evenly distributed in the central nervous system of rat. This indicates that the physiological role of the enzyme is probably not a specific degradation of enkephalins, but rather pertains to the general turnover of proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789606     DOI: 10.1007/bf00970592

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

Review 1.  Mammalian subtilisins: the long-sought dibasic processing endoproteases.

Authors:  P J Barr
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

2.  Structural comparisons of cAMP-dependent protein kinases I and II from porcine skeletal muscle.

Authors:  M J Zoller; A R Kerlavage; S S Taylor
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

3.  Activity of rat-liver phosphoprotein phosphatase on phosphopeptides formed in the cyclic AMP-dependent protein kinase reaction.

Authors:  V P Titanji; O Zetterqvist; U Ragnarsson
Journal:  FEBS Lett       Date:  1977       Impact factor: 4.124

4.  Immunological cross-reactivity between human tripeptidyl peptidase II and fibronectin.

Authors:  B Tomkinson; O Zetterqvist
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

5.  Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens.

Authors:  Q Z Zhai; S Persson; C Post; F Nyberg
Journal:  Neuropharmacology       Date:  1993-07       Impact factor: 5.250

6.  A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.

Authors:  C Rose; A Camus; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing.

Authors:  B Tomkinson
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

8.  Purification, substrate specificity, and classification of tripeptidyl peptidase II.

Authors:  R M Bålöw; B Tomkinson; U Ragnarsson; O Zetterqvist
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

9.  Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha.

Authors:  B Bauvois; J Sancéau; J Wietzerbin
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

10.  Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors.

Authors:  C Llorens-Cortes; C Gros; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1985-12-17       Impact factor: 4.432

View more
  2 in total

Review 1.  The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain.

Authors:  Robert C Speth; Vardan T Karamyan
Journal:  Heart Fail Rev       Date:  2008-01-09       Impact factor: 4.214

2.  Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2.

Authors:  Anne Wiemhoefer; Anita Stargardt; Wouter A van der Linden; Maria C Renner; Ronald E van Kesteren; Jan Stap; Marcel A Raspe; Birgitta Tomkinson; Helmut W Kessels; Huib Ovaa; Herman S Overkleeft; Bogdan Florea; Eric A Reits
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.